| Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study A Pearce, M Haas, R Viney, SA Pearson, P Haywood, C Brown, R Ward PloS one 12 (10), e0184360, 2017 | 585 | 2017 |
| Discrete choice experiments to measure consumer preferences for health and healthcare R Viney, E Lancsar, J Louviere Expert review of pharmacoeconomics & outcomes research 2 (4), 319-326, 2002 | 286 | 2002 |
| Time trade-off derived EQ-5D weights for Australia R Viney, R Norman, MT King, P Cronin, DJ Street, S Knox, J Ratcliffe Value in Health 14 (6), 928-936, 2011 | 270 | 2011 |
| Quality of life and survival in the 2 years after surgery for non–small-cell lung cancer PM Kenny, MT King, RC Viney, MJ Boyer, CA Pollicino, JM McLean, ... Journal of Clinical Oncology 26 (2), 233-241, 2008 | 221 | 2008 |
| Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer RC Viney, MJ Boyer, MT King, PM Kenny, CA Pollicino, JM McLean, ... Journal of Clinical Oncology 22 (12), 2357-2362, 2004 | 221 | 2004 |
| Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination J Hall, P Kenny, M King, J Louviere, R Viney, A Yeoh Health economics 11 (5), 457-465, 2002 | 211 | 2002 |
| Using stated preference discrete choice modeling to evaluate health care programs J Hall, R Viney, M Haas, J Louviere Journal of Business research 57 (9), 1026-1032, 2004 | 187 | 2004 |
| A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states R Norman, P Cronin, R Viney Applied health economics and health policy 11, 287-298, 2013 | 186 | 2013 |
| International comparisons in valuing EQ-5D health states: a review and analysis R Norman, P Cronin, R Viney, M King, D Street, J Ratcliffe Value in Health 12 (8), 1194-1200, 2009 | 185 | 2009 |
| An Australian discrete choice experiment to value EQ‐5D health states R Viney, R Norman, J Brazier, P Cronin, MT King, J Ratcliffe, D Street Health Economics 23 (6), 729-742, 2014 | 137 | 2014 |
| Empirical investigation of experimental design properties of discrete choice experiments in health care R Viney, E Savage, J Louviere Health Economics 14 (4), 349-362, 2005 | 136 | 2005 |
| Valuing SF-6D health states using a discrete choice experiment R Norman, R Viney, J Brazier, L Burgess, P Cronin, M King, J Ratcliffe, ... Medical Decision Making 34 (6), 773-786, 2014 | 122 | 2014 |
| Preferences for cancer treatments: an overview of methods and applications in oncology P Blinman, M King, R Norman, R Viney, MR Stockler Annals of oncology 23 (5), 1104-1110, 2012 | 118 | 2012 |
| QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30 MT King, DSJ Costa, NK Aaronson, JE Brazier, DF Cella, PM Fayers, ... Quality of Life Research 25, 625-636, 2016 | 115 | 2016 |
| Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review B Parkinson, C Sermet, F Clement, S Crausaz, B Godman, S Garner, ... Pharmacoeconomics 33, 905-924, 2015 | 105 | 2015 |
| Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task R Norman, MT King, D Clarke, R Viney, P Cronin, D Street Quality of Life Research 19, 499-508, 2010 | 104 | 2010 |
| Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30 MT King, R Viney, A Simon Pickard, D Rowen, NK Aaronson, JE Brazier, ... Pharmacoeconomics 36, 225-238, 2018 | 96 | 2018 |
| Carrots and sticks—the fall and fall of private health insurance in Australia J Hall, R de Abreu Lourenco, R Viney Health Economics 8 (8), 653-660, 1999 | 96 | 1999 |
| Breaking up is hard to do: why disinvestment in medical technology is harder than investment M Haas, J Hall, R Viney, G Gallego Australian Health Review 36 (2), 148-152, 2012 | 77 | 2012 |
| The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002–4 PA Scuffham, JA Whitty, A Mitchell, R Viney Pharmacoeconomics 26, 297-310, 2008 | 76 | 2008 |
Marion HaasProfessor of Health Economics, University of Technology, Sydney在 chere.uts.edu.au 的电子邮件经过验证
